10 devices · 10 companies · 1995 to 2026

AI-enabled pathology devices on FDA's list

10 devices in the Pathology panel, 1995 to 2026, from 10 companies across 9 product codes. Each record carries FDA's decision, the Indications for Use statement verbatim where the public document carries one (8 of 10 here), the regulation, and MAUDE report counts by product code.

Retrieved from FDA public records.

Product codes in the Pathology panel

Companies with more than one device here

Every device, newest decision first

Pathology · 10 devices
DecisionDeviceCompanyProduct codeFDA
ArteraAI BreastK254115 · 510(k)Artera, Inc.SHWdatabase entry
INFINITT DPSK243449 · 510(k)Infinitt Healthcare Co., Ltd.QKQdatabase entry
GENESEEQPRIME NGS Tumor Profiling AssayK250003 · 510(k)Geneseeq Technology Inc.PZMdatabase entry
ArteraAI ProstateDEN240068 · De NovoArtera Inc.SFHdatabase entry
Galen Second ReadK241232 · 510(k)Ibex Medical Analytics Ltd.QPNdatabase entry
“Genius Digital Diagnostics System with the GeniDEN210035 · De NovoHologic Inc.QYVdatabase entry
xT CDxP210011 · PMATempus Labs, Inc.PQPdatabase entry
Paige ProstateDEN200080 · De NovoPaige.AIQPNdatabase entry
PAPNET Testing SystemP940029 · PMANeuromedical Systems, Inc.MNMdatabase entry
AUTOPAPP950009 · PMABD DIAGNOSTICSNMNdatabase entry

Every panel in the record, the whole record of FDA AI-enabled medical devices, or what Apodicta does on a medical record.

Show me on one of my files →

Every device here is authorized for a stated use. See a record read against what it must prove, on your own file.

Show me on my files